تحميل...

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

BACKGROUND: COVID-19 threatens to quickly overwhelm our existing critical care infrastructure in the USA. Systemic tissue plasminogen activator (tPA) has been previously demonstrated to improve PaO(2)/FiO(2) (mmHg) when given to critically ill patients with acute respiratory distress syndrome (ARDS)...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	World J Emerg Surg
المؤلفون الرئيسيون:	Choudhury, Rashikh, Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Talmor, Daniel S., Nydam, Trevor L., Yaffe, Michael B.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BioMed Central 2020
الموضوعات:	Commentary
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7169373/ https://ncbi.nlm.nih.gov/pubmed/32312290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13017-020-00305-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

مواد مشابهة